Data Mining & Bioinformatics

1. Protein Structure Prediction with Graph Neural Networks

Within bioinformatics, Graph‑Neural‑Network (GNN)‑based protein‑structure prediction models proteins as graphs: nodes represent amino‑acid residues and edges denote interactions or spatial adjacency between residues. Combined with data‑mining techniques extracting features from large‑scale protein‑sequence and structure databases, GNNs automatically learn protein‑folding patterns. They effectively capture local and global topological protein features and predict residue distances or 3D coordinates by aggregating neighborhood information, greatly improving prediction accuracy. Such approaches accelerate protein‑function interpretation and provide efficient computational tools for drug‑target design and disease‑mechanism research.

2. Drug Prediction and Discovery

For drug prediction and discovery combining bioinformatics and data mining, researchers integrate multi‑source heterogeneous data including genomics, proteomics and metabolomics, together with chemical databases and bioactivity records. Machine‑learning approaches such as deep learning and graph neural networks analyze drug‑target interactions and predict compound efficacy and toxicity. Data‑mining techniques extract potential candidate drug molecules from massive literature and experimental datasets, and virtual screening accelerates candidate optimization. These methods substantially shorten traditional drug‑research cycles, support drug repositioning (new uses for existing drugs) and novel‑compound design, delivering efficient low‑cost solutions for precision medicine and disease treatment.

3. Interaction Analysis

Data‑mining‑driven interaction analysis in bioinformatics uncovers functional association networks among biomolecules (protein‑protein, drug‑target, gene‑regulator, etc.). Multi‑omics datasets (genomics, transcriptomics, proteomics) and public databases such as STRING and KEGG are integrated. Graph‑network modeling, random‑walk algorithms or deep‑learning models including GNNs and attention mechanisms systematically mine hidden interaction patterns and dynamic regulatory mechanisms. It identifies disease‑related pathways, predicts potential drug targets or toxic responses, providing data‑driven theoretical support for understanding complex biological systems, optimizing therapeutic schemes and developing multi‑target drugs.

4. Microbiome Distribution and Mining

Microbiome‑distribution research based on data mining integrates multi‑source datasets such as metagenomics, metabolomics and environmental variables. High‑throughput sequencing characterizes composition and dynamic shifts of microbial communities. Machine‑learning methods (Random Forest, network analysis) and statistical models (α/β‑diversity analysis, LefSe differential testing) uncover correlations between microbial community structures and environmental or host phenotypic traits (disease, nutrition status). Key functional species and symbiotic networks are identified. These findings reveal interaction mechanisms within complex ecosystems such as the human gut or soil, support microbiome‑intervention strategies for precision medicine, and advance disease diagnosis, ecological restoration and agricultural microbial‑resource exploitation.

5. Community Detection and Complex Networks

Community‑detection and complex‑network analysis for bioinformatics identify functional modular structures within biological networks such as protein‑interaction networks, gene co‑expression networks or microbial symbiosis networks. Graph‑theoretic algorithms (Louvain, modularity maximization) and machine‑learning models, combined with multi‑omics and public database resources (STRING, KEGG), detect tightly connected subnetworks (communities). Their associations with specific biological functions, disease pathways and environmental adaptability are further explored. Critical hub nodes and unknown functional modules are predicted; dynamic network properties including robustness and hierarchy are interpreted. This delivers theoretical foundations for disease‑mechanism studies, multi‑target drug design and synthetic‑biology network reconstruction, supporting modular analysis and precise regulation of complex biological systems.

6. Knowledge Graphs

Bioinformatics‑oriented knowledge graphs construct structured biomedical entity‑relationship networks by integrating heterogeneous data on genes, proteins, diseases, drugs and academic literature. Natural‑language processing (NLP) extracts association rules from publications. Graph databases such as Neo4j and graph‑embedding techniques including TransE and GNNs systematically characterize biomolecular interactions, disease‑gene correlations and drug‑action mechanisms. Knowledge graphs support semantic reasoning and cross‑domain association mining, accelerating drug repositioning, disease‑target prediction and multi‑omics data fusion. They deliver interpretable intelligent‑decision frameworks for precision‑medicine research, complex‑disease‑mechanism analysis and interdisciplinary studies.